The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non-small cell lung cancer with sensitive EGFR mutations.
Jiang Y, Lin Y, Fu W, He Q, Liang H, Zhong R, Cheng R, Li B, Wen Y, Wang H, Li J, Li C, Xiong S, Chen S, Xiang J, Mann MJ, He J, Liang W.
Jiang Y, et al. Among authors: li c, li j, li b.
EClinicalMedicine. 2023 Sep 14;64:102205. doi: 10.1016/j.eclinm.2023.102205. eCollection 2023 Oct.
EClinicalMedicine. 2023.
PMID: 37745018
Free PMC article.